Co-GP / Platform:A family office could deploy into the San Diego life sciences market by backing a sponsor or operator at the GP level, sharing in the promote and accessing a repeatable deal flow.

Co-GP / Platform:A family office could deploy into this market by backing a sponsor/operator at the GP level to share in the promote and capitalize on the growing life sciences sector.

Co-GP / Platform:A family office could deploy into this market by backing a life sciences operator at the GP level, sharing in the promote and accessing a pipeline of investment opportunities.

Co-GP / Platform:A family office could deploy into the Denver life sciences market by backing a sponsor or operator at the GP level, focusing on those with a proven track record in capitalizing on emerging biotech firms.

Co-GP / Platform:A family office could deploy into the San Francisco life sciences market by backing a sponsor or operator at the GP level to share in the promote and access a repeatable deal flow.

Co-GP / Platform:A family office could deploy into the Philadelphia life sciences market by backing a sponsor/operator at the GP level to share in the promote and access a pipeline of investment opportunities.

Co-GP / Platform:A family office could deploy into the life sciences market by backing a sponsor/operator at the GP level, sharing in the promote and accessing a pipeline of lab space developments.

Co-GP / Platform:A family office could deploy into the Boston life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from the sector's growth.

Co-GP / Platform:A family office could deploy into the Washington D.C. life sciences market by backing a sponsor or operator at the GP level to share in the promote and access a pipeline of investment opportunities.

Co-GP / Platform:A family office could deploy into this market by backing a life sciences operator at the GP level to share in the promote and access a repeatable pipeline of investment opportunities.

Co-GP / Platform:A family office could deploy into the San Diego life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the Raleigh life sciences market by backing a sponsor/operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the life sciences market by partnering with a sponsor to co-GP or invest in JV equity, sharing in the promote while accessing a pipeline of opportunities.

Co-GP / Platform:A family office could deploy into the life sciences market by backing a specialized operator at the GP level, engaging in co-GP or JV equity arrangements to share in the promote.

Co-GP / Platform:A family office could deploy into the Bay Area life sciences market by backing a sponsor or operator at the GP level, sharing in the promote and benefiting from a robust pipeline.

Co-GP / Platform:A family office could deploy into the life sciences market by backing a sponsor with a proven track record in developing and managing life sciences properties, sharing in the promote and enterprise value.

Co-GP / Platform:A family office could deploy into the Denver life sciences market by backing a sponsor/operator at the GP level to share in the promote and benefit from a repeatable pipeline.

Co-GP / Platform:A family office could deploy into the New York City life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from a repeatable pipeline.

Co-GP / Platform:A family office could deploy into the Philadelphia life sciences market by backing a sponsor or operator at the GP level to share in the promote and access a repeatable pipeline.

Co-GP / Platform:A family office could deploy into the Boston life sciences market by backing a sponsor/operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the Boston life science market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the Philadelphia life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the Northern California life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from a robust pipeline.

Co-GP / Platform:A family office could deploy into the New York City life sciences market by backing a sponsor or operator at the GP level, focusing on co-GP or JV equity to share in the promote.